dalteparin has been researched along with Anti-Phospholipid Antibody Syndrome in 63 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia." | 8.90 | Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. ( de Jong, PG; Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2014) |
| "The present study suggests that pravastatin may improve pregnancy outcomes in women with refractory obstetric APS when taken at the onset of PE or IUGR until the end of pregnancy." | 7.83 | Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy. ( Dagklis, T; Girardi, G; Lefkou, E; Mamopoulos, A; Rousso, D; Vosnakis, C, 2016) |
| "The aim of this retrospective, observational study was to determine the impact of low-dose enoxaparin (20 mg) in conjunction with low-dose aspirin on the pregnancy outcome of women with antiphospholipid syndrome and recurrent miscarriage." | 7.75 | Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin. ( Li, TC; Makris, M; Metwally, M; Mo, D; Saravelos, S, 2009) |
| "Stasis ulcers are commonly the result of chronic venous insufficiency." | 5.31 | Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report. ( Bick, RL; Scott, RG, 2001) |
| "To determine whether low molecular weight heparin (LMWH) plus low-dose aspirin (LDA) is comparable in efficacy and safety to unfractionated heparin (UFH) plus LDA in the management of pregnant women with a history of recurrent spontaneous abortion secondary to antiphospholipid syndrome (APS)." | 5.15 | Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome. ( Abdou, AM; Fouda, IM; Fouda, UM; Ramadan, DI; Sayed, AM; Zaki, MM, 2011) |
| " The women were randomized, using a random numbers table with blocks of 12, to receive either prophylactic dosing of dalteparin or UFH starting either preconceptionally or early in pregnancy." | 5.11 | Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. ( Ballem, PJ; Ensom, MH; Ensworth, S; Houlihan, E; Purkiss, S; Stephenson, MD; Tsang, P, 2004) |
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia." | 4.90 | Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. ( de Jong, PG; Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2014) |
| " Low dose aspirin should be given to every pregnant woman with antiphospholipid antibodies, with the addition of low molecular weight heparin in those with previous thrombosis, previous fetal death or failure of monotherapy with aspirin." | 4.85 | [The antiphospholipid syndrome in the 21st century]. ( Egurbide, MV; Martinez-Berriotxoa, A; Ruiz-Irastorza, G, 2009) |
| " A case report is detailed of a 28-year-old woman with antiphospholipid syndrome on warfarin for high risk of venous thrombosis who underwent tonsillectomy." | 4.84 | Tonsillectomy in the anticoagulated patient. ( Cole, SM; Cupp, CL; Patterson, MB, 2007) |
| "The present study suggests that pravastatin may improve pregnancy outcomes in women with refractory obstetric APS when taken at the onset of PE or IUGR until the end of pregnancy." | 3.83 | Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy. ( Dagklis, T; Girardi, G; Lefkou, E; Mamopoulos, A; Rousso, D; Vosnakis, C, 2016) |
| " She is currently on warfarin, with which she has been adequately controlled most of the time, presenting with only one haemorrhagic event consisting of haematuria and prolonged international normalised ratio (INR) without bleeding." | 3.81 | Variability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: should the INR targets be higher? ( Baquero-Salamanca, M; Calderon-Ospina, C; Téllez-Arévalo, AM, 2015) |
| "The aim of this retrospective, observational study was to determine the impact of low-dose enoxaparin (20 mg) in conjunction with low-dose aspirin on the pregnancy outcome of women with antiphospholipid syndrome and recurrent miscarriage." | 3.75 | Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin. ( Li, TC; Makris, M; Metwally, M; Mo, D; Saravelos, S, 2009) |
| " Aspirin, 75 mg daily was given in addition to enoxaparin to women with antiphospholipid syndrome." | 3.70 | Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. ( Blumenfeld, Z; Brenner, B; Hoffman, R; Weiner, Z; Younis, JS, 2000) |
| "The antiphospholipid syndrome is described with a review of its historical development as a recognized syndrome, what constitutes an antiphospholipid antibody, how it is measured, and how the syndrome is treated." | 2.43 | The antiphospholipid syndrome: what are we really measuring? How do we measure it? And how do we treat it? ( Ortel, TL, 2006) |
| "Antiphospholipid syndrome is an autoimmune disease characterized by vascular thrombosis involving both the arterial and venous systems that can lead to tissue ischemia or end-organ damage." | 1.51 | The Solitary Blue Toe: A Unique Presentation of Antiphospholipid Syndrome. ( Dimond, DG; Driscoll, K; Kiser, C; Lam, JK; Razzante, M; Wurster, L, 2019) |
| ": Lupus anticoagulant hypoprothrombinemia syndrome (LAHS) is a rare disorder characterized by development of lupus anticoagulant and antiprothrombin antibodies." | 1.48 | Fatal pulmonary embolism and pulmonary hemorrhage in lupus anticoagulant hypoprothrombinemia syndrome: a case report and review of literature. ( Chen, X; Cunningham, MT; Nedved, D; Plapp, FV, 2018) |
| "One patient had deep venous thrombosis in the 6 weeks postpartum, in the GROUP P." | 1.46 | Is a therapeutic anticoagulation window needed for delivery when using prophylactic low molecular weight heparin during pregnancy? A retrospective monocentric study. ( Agman, A; Amsellem, J; Cesario, E; Nizard, J; Roueli, A; Vauthier-Brouzes, D, 2017) |
| "The antiphospholipid antibody syndrome is defined by the presence of antiphospholipid antibodies in patients with recurrent venous or arterial thromboembolism (1)." | 1.43 | Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome. ( Brzosko, M; Przepiera-Będzak, H, 2016) |
| " Thrombotic storm was defined as newly diagnosed multisite venous thromboembolism (VTE) with acute thrombus progression despite conventional or higher than conventional dosing of heparin or low molecular weight heparin." | 1.38 | Treatment, survival, and thromboembolic outcomes of thrombotic storm in children. ( Gibson, E; Goldenberg, NA; Knoll, CM; Manco-Johnson, MJ; Mourani, PM; Soep, J; Wang, M, 2012) |
| "It led to a complete resolution of the thrombus in 4 weeks without the need for a high-risk operation in this patient." | 1.35 | Cardioverter-defibrillator lead-related thrombus treated with prolonged anticoagulation in patient with prothrombotic disorder. ( Chojnowska, L; Hoffman, P; Klopotowski, M; Konka, M; Maczynska, R; Malek, LA; Ruzyllo, W; Skwarek, M, 2008) |
| " The results of this study indicate that nadroparin alone is useful and safe in the management of pregnant patients with APS." | 1.33 | Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome: a prospective cohort study. ( Chiarelli, S; De Silvestro, G; Fais, G; Favaro, M; Pengo, V; Ruffatti, A; Suma, V; Todesco, S; Tonello, M, 2005) |
| "We suppose that cocaine abuse may have had a delayed effect as trigger of acute myocardial infarction." | 1.33 | Acute myocardial infarction in a young woman with antiphospholipid syndrome and occasional cocaine abuse. ( Dei Cas, L; Pedrinazzi, C; Procopio, R; Raddino, R; Zanini, G, 2005) |
| "Hypercoaguable states such as the antiphospholipid antibody syndrome may be associated with thromboses in any vascular bed." | 1.33 | Budd-Chiari syndrome, systemic lupus erythematosus, and secondary antiphospholipid antibody syndrome in pregnancy. ( Aisenbrey, GA; Argubright, KF; Joffe, GM, 2005) |
| " In this report, we describe a woman with primary antiphospholipid antibody syndrome who developed extensive pulmonary embolism despite receiving a proven therapeutic dosage of low molecular weight heparin." | 1.31 | Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome. ( Ahmed, S; Karim, A; Mattana, J; Patel, D; Siddiqui, R, 2002) |
| "Stasis ulcers are commonly the result of chronic venous insufficiency." | 1.31 | Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report. ( Bick, RL; Scott, RG, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (4.76) | 18.2507 |
| 2000's | 33 (52.38) | 29.6817 |
| 2010's | 26 (41.27) | 24.3611 |
| 2020's | 1 (1.59) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, PG | 1 |
| Kaandorp, S | 1 |
| Di Nisio, M | 1 |
| Goddijn, M | 1 |
| Middeldorp, S | 1 |
| Frank, M | 1 |
| Sodin-Semrl, S | 1 |
| Rozman, B | 1 |
| Potocnik, M | 1 |
| Kralj-Iglic, V | 1 |
| Makatsaria, AD | 1 |
| Bitsadze, VO | 1 |
| Dolgushina, NV | 1 |
| Ruffatti, A | 2 |
| Favaro, M | 2 |
| Tonello, M | 2 |
| De Silvestro, G | 2 |
| Pengo, V | 2 |
| Fais, G | 1 |
| Suma, V | 1 |
| Chiarelli, S | 1 |
| Todesco, S | 1 |
| Marson, P | 1 |
| Bortolati, M | 1 |
| Minucci, D | 1 |
| Stojanovich, L | 1 |
| Mikovic, Z | 1 |
| Mandic, V | 1 |
| Popovich-Kuzmanovich, D | 1 |
| Perunicic, J | 1 |
| Antonijevic, NM | 1 |
| Miljic, P | 1 |
| Djordjevic, V | 1 |
| Mikovic, D | 1 |
| Kovac, M | 1 |
| Djokic, M | 1 |
| Mrdovic, I | 1 |
| Nikolic, A | 1 |
| Vasiljevic, Z | 1 |
| Arnout, J | 1 |
| Spitz, B | 1 |
| Wittevrongel, C | 1 |
| Vanrusselt, M | 1 |
| Van Assche, A | 1 |
| Vermylen, J | 1 |
| Karag'ozova, Zh | 1 |
| Chernev, T | 1 |
| Iankova, Z | 1 |
| Baleva, M | 1 |
| Dimitrov, A | 1 |
| Alalaf, S | 1 |
| Dabas, G | 1 |
| De, D | 1 |
| Handa, S | 1 |
| Aggarwal, D | 1 |
| Sudhakar, D | 1 |
| Kamran, H | 1 |
| Chen, N | 1 |
| Mims, M | 1 |
| Hamzeh, I | 1 |
| Roueli, A | 1 |
| Cesario, E | 1 |
| Amsellem, J | 1 |
| Agman, A | 1 |
| Vauthier-Brouzes, D | 1 |
| Nizard, J | 1 |
| Chen, X | 1 |
| Nedved, D | 1 |
| Plapp, FV | 1 |
| Cunningham, MT | 1 |
| Dimond, DG | 1 |
| Lam, JK | 1 |
| Wurster, L | 1 |
| Kiser, C | 1 |
| Driscoll, K | 1 |
| Razzante, M | 1 |
| Roie, EV | 1 |
| Labarque, V | 1 |
| Renard, M | 1 |
| Van Geet, C | 1 |
| Gabriëls, L | 1 |
| Bouvier, S | 1 |
| Cochery-Nouvellon, E | 1 |
| Lavigne-Lissalde, G | 1 |
| Mercier, E | 1 |
| Marchetti, T | 1 |
| Balducchi, JP | 2 |
| Marès, P | 2 |
| Gris, JC | 2 |
| Baquero-Salamanca, M | 1 |
| Téllez-Arévalo, AM | 1 |
| Calderon-Ospina, C | 1 |
| Vargas-Hitos, JA | 1 |
| Sabio, JM | 1 |
| Navarrete-Navarrete, N | 1 |
| Zamora-Pasadas, M | 1 |
| Jiménez-Alonso, J | 1 |
| Ismail, AM | 1 |
| Hamed, AH | 1 |
| Saso, S | 1 |
| Abu-Elhasan, AM | 1 |
| Abu-Elghar, MM | 1 |
| Abdelmeged, AN | 1 |
| Maalouly, G | 1 |
| Ward, C | 1 |
| Smayra, V | 1 |
| Saliba, Y | 1 |
| Aftimos, G | 1 |
| Haddad, F | 1 |
| Farès, N | 1 |
| Lefkou, E | 1 |
| Mamopoulos, A | 1 |
| Dagklis, T | 1 |
| Vosnakis, C | 1 |
| Rousso, D | 1 |
| Girardi, G | 1 |
| Przepiera-Będzak, H | 1 |
| Brzosko, M | 1 |
| Alijotas-Reig, J | 2 |
| Casellas-Caro, M | 1 |
| Ferrer-Oliveras, R | 1 |
| Llurba-Olive, E | 1 |
| Hermosilla, E | 1 |
| Vilardell-Tarres, M | 1 |
| Cabero-Roura, L | 1 |
| Forsnes, E | 1 |
| Occhino, A | 1 |
| Acosta, R | 1 |
| Ruiz-Irastorza, G | 1 |
| Martinez-Berriotxoa, A | 1 |
| Egurbide, MV | 1 |
| Mo, D | 1 |
| Saravelos, S | 1 |
| Metwally, M | 1 |
| Makris, M | 1 |
| Li, TC | 1 |
| Dönmez, O | 1 |
| Durmaz, O | 1 |
| Fouda, UM | 2 |
| Sayed, AM | 2 |
| Ramadan, DI | 2 |
| Fouda, IM | 2 |
| Abdou, AM | 1 |
| Zaki, MM | 1 |
| Karow, A | 1 |
| Hainmann, I | 1 |
| Nakamura, L | 1 |
| Budde, U | 1 |
| Mueller, C | 1 |
| Zieger, B | 1 |
| Listernick, R | 1 |
| D'Ippolito, S | 1 |
| Marana, R | 1 |
| Di Nicuolo, F | 1 |
| Castellani, R | 1 |
| Veglia, M | 1 |
| Stinson, J | 1 |
| Scambia, G | 1 |
| Di Simone, N | 1 |
| Manco-Johnson, MJ | 1 |
| Wang, M | 1 |
| Goldenberg, NA | 1 |
| Soep, J | 1 |
| Gibson, E | 1 |
| Knoll, CM | 1 |
| Mourani, PM | 1 |
| Yazbek, MA | 1 |
| Velho, P | 1 |
| Nadruz, W | 1 |
| Mahayri, N | 1 |
| Appenzeller, S | 1 |
| Costallat, LT | 1 |
| Turaka, K | 1 |
| Bryan, JS | 1 |
| Kwong, HM | 1 |
| Ziemianski, MC | 1 |
| Ahmed, S | 1 |
| Karim, A | 1 |
| Patel, D | 1 |
| Siddiqui, R | 1 |
| Mattana, J | 1 |
| Ferrer-Raventos, JC | 1 |
| Kozlovskaia, NL | 1 |
| Shakhnova, EA | 1 |
| Kushnir, VV | 1 |
| Shilov, EM | 1 |
| Raddino, R | 1 |
| Pedrinazzi, C | 1 |
| Zanini, G | 1 |
| Procopio, R | 1 |
| Dei Cas, L | 1 |
| Joffe, GM | 1 |
| Aisenbrey, GA | 1 |
| Argubright, KF | 1 |
| Ortel, TL | 1 |
| Elchalal, U | 1 |
| Gabbay, E | 1 |
| Nadjari, M | 1 |
| Varon, D | 1 |
| Zelig, O | 1 |
| Ben-Chetrit, E | 1 |
| Cole, SM | 1 |
| Patterson, MB | 1 |
| Cupp, CL | 1 |
| Di Gennaro, L | 1 |
| Maggi, F | 1 |
| Novarese, L | 1 |
| Cipriani, MC | 1 |
| Bonomo, L | 1 |
| Landolfi, R | 1 |
| Bick, RL | 2 |
| Many, A | 3 |
| Tanne, D | 1 |
| Katzav, A | 1 |
| Beilin, O | 1 |
| Grigoriadis, NC | 1 |
| Blank, M | 1 |
| Pick, CG | 1 |
| Landenberg, Pv | 1 |
| Shoenfeld, Y | 1 |
| Chapman, J | 1 |
| Malek, LA | 1 |
| Chojnowska, L | 1 |
| Konka, M | 1 |
| Klopotowski, M | 1 |
| Skwarek, M | 1 |
| Maczynska, R | 1 |
| Hoffman, P | 1 |
| Ruzyllo, W | 1 |
| Dulitzki, M | 2 |
| Pauzner, R | 2 |
| Langevitz, P | 2 |
| Pras, M | 1 |
| Schiff, E | 1 |
| Brenner, B | 1 |
| Hoffman, R | 1 |
| Blumenfeld, Z | 1 |
| Weiner, Z | 1 |
| Younis, JS | 1 |
| Marietta, M | 1 |
| Bertesi, M | 1 |
| Simoni, L | 1 |
| Castelli, I | 1 |
| Cappi, C | 1 |
| Torelli, G | 1 |
| Livneh, A | 1 |
| Kenett, R | 1 |
| Quéré, I | 1 |
| Hoffet, M | 1 |
| Thachil, J | 1 |
| Dey, M | 1 |
| Charles Bates, A | 1 |
| McMillan, P | 1 |
| Ebina, Y | 1 |
| Yamada, H | 1 |
| Kato, EH | 1 |
| Yamamoto, R | 1 |
| Sakuragi, N | 1 |
| Fujimoto, S | 1 |
| Stone, S | 1 |
| Hunt, BJ | 1 |
| Seed, PT | 1 |
| Parmar, K | 1 |
| Khamashta, MA | 1 |
| Poston, L | 1 |
| Stephenson, MD | 1 |
| Ballem, PJ | 1 |
| Tsang, P | 1 |
| Purkiss, S | 1 |
| Ensworth, S | 1 |
| Houlihan, E | 1 |
| Ensom, MH | 1 |
| Korenkov, M | 1 |
| Depta, A | 1 |
| Kentner, R | 1 |
| Beck, J | 1 |
| Junginger, T | 1 |
| Shefras, J | 1 |
| Farquharson, RG | 1 |
| Scott, RG | 1 |
| Villié, P | 1 |
| Noël, N | 1 |
| Ackermann, F | 1 |
| Rivoisy, C | 1 |
| Le Pavec, J | 1 |
| Savale, L | 1 |
| Goujard, C | 1 |
| Rocher, L | 1 |
| Lambotte, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss ,Double Blinded Randomized Controlled Trial .[NCT05237843] | Phase 1 | 70 participants (Anticipated) | Interventional | 2022-03-01 | Not yet recruiting | ||
| A Randomized Clinical Trial of Using Preconceptional Enoxaparin AND Low Dose Aspirin 81mg in Patient With Antiphospholipid Syndrome(APS)[NCT01661439] | 316 participants (Anticipated) | Observational | 2012-03-31 | Recruiting | |||
| Low-molecular-weight Heparin Versus Unfractionated Heparin in Pregnant Women With History of Recurrent Abortion Secondary to Antiphospholipid Syndrome. A Randomized Controlled Trial[NCT01051778] | Phase 2 | 60 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| Genetics of Antiphospholipid Antibody Syndrome[NCT00482794] | 2,800 participants (Anticipated) | Observational | 2006-06-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Live birth occurs when a fetus (> 24 weeks ) , exits the maternal body and subsequently shows signs of life, such as voluntary movement, heartbeat, or pulsation of the umbilical cord. (NCT01051778)
Timeframe: pregnancy > 24weeks gestation
| Intervention | Percentage of pregnancies (Number) |
|---|---|
| Enoxaparin 40 mg /Day Plus Low Dose Aspirin | 24 |
| Heparin Calcium 5,000 U Twice Daily Plus Low Dose Aspirin | 20 |
9 reviews available for dalteparin and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Enoxaparin; Female; Heparin, | 2014 |
Use of the low-molecular-weight heparin nadroparin during pregnancy. A review.
Topics: Antiphospholipid Syndrome; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Herpes Simplex; Huma | 2003 |
Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Female; Humans; Immunoglobulins, Intravenous; Nadr | 2007 |
[Application of low-molecular-weight heparin during pregnancy and delivery in case of reproductive failure due to antiphospholipid syndrome].
Topics: Adult; Antiphospholipid Syndrome; Blood Coagulation; Cesarean Section; Female; Heparin, Low-Molecula | 2000 |
[The antiphospholipid syndrome in the 21st century].
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Tri | 2009 |
The antiphospholipid syndrome: what are we really measuring? How do we measure it? And how do we treat it?
Topics: Aged; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; beta 2-Glycoprotein I | 2006 |
Tonsillectomy in the anticoagulated patient.
Topics: Adult; Algorithms; Anticoagulants; Antiphospholipid Syndrome; Blood Loss, Surgical; Dose-Response Re | 2007 |
Antiphospholipid syndrome in pregnancy.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2008 |
Life-threatening Hughes-Stovin syndrome: The Yin and Yang of anticoagulation therapy.
Topics: Adrenal Cortex Hormones; Adult; Anticoagulants; Antiphospholipid Syndrome; Behcet Syndrome; Critical | 2016 |
7 trials available for dalteparin and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Embryo Loss; Female; Heparin, Low-Mol | 2012 |
Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Egypt; Eno | 2016 |
Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Enoxaparin; Female; Humans; In | 2010 |
Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2011 |
Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune D | 2001 |
Enoxaparin sodium improves pregnancy outcome in aspirin-resistant antiphospholipid/antiprotein antibody syndromes.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Resistance; Enoxaparin; | 2002 |
Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dalteparin; Female; Heparin; Humans; Pilo | 2004 |
47 other studies available for dalteparin and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Effects of low-molecular-weight heparin on adhesion and vesiculation of phospholipid membranes: a possible mechanism for the treatment of hypercoagulability in antiphospholipid syndrome.
Topics: Adsorption; Antibodies, Monoclonal; Anticoagulants; Antiphospholipid Syndrome; Autoantibodies; beta | 2009 |
Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome: a prospective cohort study.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Female; Follow-Up St | 2005 |
Treatment of antiphospholipid syndrome in pregnancy with low doses of intravenous immunoglobulin.
Topics: Adult; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Autoantibodies; Dexamethasone; Dose-Resp | 2007 |
Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome.
Topics: Administration, Oral; Adult; Antibodies; Anticoagulants; Antiphospholipid Syndrome; Diagnosis, Diffe | 2008 |
High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome.
Topics: Adult; Antibodies, Anti-Idiotypic; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; | 1994 |
Delayed-type hypersensitivity reaction to enoxaparin in a pregnant woman.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Enoxaparin; Female; Humans; Hypersensitivity, Dela | 2019 |
A Sticky Situation: Aortic Valve Thrombus in Patient with Antiphospholipid Antibody Syndrome and Immune Thrombocytopenia.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aortic Valve; Aortic Valve Stenosis; Benzoates; Bi | 2020 |
Is a therapeutic anticoagulation window needed for delivery when using prophylactic low molecular weight heparin during pregnancy? A retrospective monocentric study.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Delivery, Obstetric; Enoxaparin; Female; Heparin, | 2017 |
Fatal pulmonary embolism and pulmonary hemorrhage in lupus anticoagulant hypoprothrombinemia syndrome: a case report and review of literature.
Topics: Aged; Anticoagulants; Antiphospholipid Syndrome; Enoxaparin; Fatal Outcome; Female; Gastrointestinal | 2018 |
The Solitary Blue Toe: A Unique Presentation of Antiphospholipid Syndrome.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Blue Toe Syndrome; Computed | 2019 |
Obsessive-compulsive behavior as presenting symptom of primary antiphospholipid syndrome.
Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Caudate Nucleus; Diagnosis, Differential; Eno | 2013 |
Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adolescent; Adult; Antibodies, Anticardiolipin; Antibodie | 2014 |
Variability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: should the INR targets be higher?
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Enoxaparin; Female; Hematuria; Hemorrhage; Humans; | 2015 |
Severe digital necrosis as the clinical onset of antiphospholipid syndrome.
Topics: Aged; Antiphospholipid Syndrome; Enoxaparin; Fibrinolytic Agents; Humans; Male; Necrosis | 2016 |
Fish oil attenuates neurologic severity of antiphospholipid syndrome in a mice experimental model.
Topics: Animals; Antiphospholipid Syndrome; Anxiety; Behavior, Animal; Brain; Curcumin; Disease Models, Anim | 2017 |
Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.
Topics: Adult; Antiphospholipid Syndrome; Endothelium; Enoxaparin; Female; Fibrinolytic Agents; Gestational | 2016 |
Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
Topics: Acquired Hyperostosis Syndrome; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Enoxa | 2016 |
Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants | 2008 |
Spontaneous spinal epidural hematoma in pregnancy associated with using low molecular weight heparin.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Cesarean Section; Enoxaparin; Female; Hematoma, Ep | 2009 |
Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dose-Response Relatio | 2009 |
Calcinosis cutis universalis with pediatric systemic lupus erythematosus.
Topics: Administration, Oral; Antiphospholipid Syndrome; Aspirin; Calcinosis; Child; Cyclosporine; Dermatolo | 2010 |
Progressive thrombosis in a 13-year-old girl with trisomy 21 under therapy with low molecular weight heparin.
Topics: Adolescent; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Antithrombins; | 2011 |
A 15-year-old girl with hypertension.
Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Cerebral Infarction; Enoxaparin; Female; Huma | 2011 |
Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesis.
Topics: Adult; Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Dose-Response Relationship, | 2012 |
Treatment, survival, and thromboembolic outcomes of thrombotic storm in children.
Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Child; Child, Preschool; Cytokines; Enoxapari | 2012 |
Extensive skin necrosis induced by low-molecular-weight heparin in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Eruptions; Drug Therapy, Combination; Enoxaparin; Female; F | 2012 |
Bilateral occlusive retinal vasculitis in a patient with primary antiphospholipid antibody syndrome.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiphospholipid Syndrom | 2012 |
Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.
Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Arginine; Arm; Enoxaparin; Female; Folic Acid | 2002 |
Life-threatening bleeding, pregnancy and lupus anticoagulant: success after steroid and anticoagulant therapy.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Glucocorticoids; | 2004 |
[Low-molecular heparins in the treatment of APS-nephropathy in primary and secondary antiphospholipid syndrome].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Case-Control Studies; Enoxaparin; Female; Humans; | 2004 |
Acute myocardial infarction in a young woman with antiphospholipid syndrome and occasional cocaine abuse.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Cocaine-Related Disorders; Coronary | 2005 |
Budd-Chiari syndrome, systemic lupus erythematosus, and secondary antiphospholipid antibody syndrome in pregnancy.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Budd-Chiari Syndrome; Cholecystectom | 2005 |
Catastrophic antiphospholipid syndrome in the second trimester of pregnancy.
Topics: Abortion, Induced; Adult; Anti-Inflammatory Agents; Anticoagulants; Antineoplastic Agents, Hormonal; | 2006 |
Bilateral axillary vein thrombosis in a young patient with lupus anticoagulant and clavicular bone spurs.
Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Axillary Vein; Clavicle; Enoxaparin; Humans; | 2007 |
Preventing death in catastrophic antiphospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Enoxaparin; Humans; International Normalized Ratio | 2008 |
Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome.
Topics: Alprostadil; Analysis of Variance; Animals; Antiphospholipid Syndrome; Aspirin; Behavior, Animal; be | 2008 |
Cardioverter-defibrillator lead-related thrombus treated with prolonged anticoagulation in patient with prothrombotic disorder.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Defibrillators, Implantable; Echocardiography; Eno | 2008 |
Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies.
Topics: Adult; Antiphospholipid Syndrome; Enoxaparin; Female; Fibrinolytic Agents; Humans; Labor, Obstetric; | 1996 |
Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Topics: 3' Untranslated Regions; Abortion, Habitual; Activated Protein C Resistance; Adult; Anticoagulants; | 2000 |
Cerebral vein thrombosis and lupus anticoagulant antibodies.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Autoimmune Diseases; Enoxaparin; Female; Humans; L | 2001 |
Should low molecular weight heparin dosing be based on anti-Xa assays in antiphospholipid syndrome?
Topics: Adult; Anti-Bacterial Agents; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome | 2013 |
Superior ophthalmic vein thrombosis as an initial manifestation of antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Dalteparin; Drug Therapy, Combination; Exophthalmo | 2013 |
Thromboprophylaxis with low molecular weight heparin in thrombophilia-complicated pregnancy.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Dalteparin; Female; Humans; Pregnancy; Pregnancy C | 2002 |
Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Dalteparin; Endothelium, Vascular; F | 2003 |
[Paraneoplastic lupus anticoagulans syndrome].
Topics: Anticoagulants; Antiphospholipid Syndrome; Dalteparin; Female; Fibrinolytic Agents; Follow-Up Studie | 2005 |
Bone density studies in pregnant women receiving heparin.
Topics: Anticoagulants; Antiphospholipid Syndrome; Bone Density; Case-Control Studies; Dalteparin; Female; H | 1996 |
Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antiphospholipid Syndrome; Clopidogrel; Dalteparin; | 2001 |